These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17332675)

  • 41. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects.
    Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
    Int Angiol; 2014 Jun; 33(3):243-54. PubMed ID: 24936533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.
    Becker BF; Jacob M; Leipert S; Salmon AH; Chappell D
    Br J Clin Pharmacol; 2015 Sep; 80(3):389-402. PubMed ID: 25778676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus.
    Broekhuizen LN; Lemkes BA; Mooij HL; Meuwese MC; Verberne H; Holleman F; Schlingemann RO; Nieuwdorp M; Stroes ES; Vink H
    Diabetologia; 2010 Dec; 53(12):2646-55. PubMed ID: 20865240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface.
    Constantinescu AA; Vink H; Spaan JA
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1541-7. PubMed ID: 12855481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.
    Dogné S; Flamion B; Caron N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1427-1439. PubMed ID: 29880486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macro and microheterogeneity in normal endothelial cells: differential composition of luminal glycocalyx and functional implications.
    Brouland JP; Gilbert MA; Bonneau M; Pignaud G; Bal Dit Solier C; Drouet L
    Endothelium; 1999; 6(3):251-62. PubMed ID: 10365776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target.
    Harding IC; Mitra R; Mensah SA; Nersesyan A; Bal NN; Ebong EE
    Biorheology; 2019; 56(2-3):131-149. PubMed ID: 30988234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease.
    Broekhuizen LN; Mooij HL; Kastelein JJ; Stroes ES; Vink H; Nieuwdorp M
    Curr Opin Lipidol; 2009 Feb; 20(1):57-62. PubMed ID: 19106708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Damage of the endothelial glycocalyx in dialysis patients.
    Vlahu CA; Lemkes BA; Struijk DG; Koopman MG; Krediet RT; Vink H
    J Am Soc Nephrol; 2012 Nov; 23(11):1900-8. PubMed ID: 23085635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The structure and function of the endothelial glycocalyx layer.
    Weinbaum S; Tarbell JM; Damiano ER
    Annu Rev Biomed Eng; 2007; 9():121-67. PubMed ID: 17373886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Damage of the endothelial glycocalyx in chronic kidney disease.
    Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
    Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial glycocalyx and the peritoneal barrier.
    Flessner MF
    Perit Dial Int; 2008; 28(1):6-12. PubMed ID: 18178940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanics of endothelial cell architecture and vascular permeability.
    Baldwin AL; Thurston G
    Crit Rev Biomed Eng; 2001; 29(2):247-78. PubMed ID: 11417757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the glomerular endothelium in albumin handling.
    Satchell S
    Nat Rev Nephrol; 2013 Dec; 9(12):717-25. PubMed ID: 24080802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is the systemic microvascular endothelial glycocalyx in peritoneal dialysis patients related to peritoneal transport?
    Vlahu CA; Lopes Barreto D; Struijk DG; Vink H; Krediet RT
    Nephron Clin Pract; 2014; 128(1-2):159-65. PubMed ID: 25376179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxia induced disruption of the cardiac endothelial glycocalyx: implications for capillary permeability.
    Ward BJ; Donnelly JL
    Cardiovasc Res; 1993 Mar; 27(3):384-9. PubMed ID: 7683973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelial glycocalyx in health and kidney disease: Rising star or false Dawn?
    Liew H; Roberts MA; MacGinley R; McMahon LP
    Nephrology (Carlton); 2017 Dec; 22(12):940-946. PubMed ID: 28846193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in the understanding of endothelial barrier function and fluid therapy.
    Thind GS; Zanders S; Baker JK
    Postgrad Med J; 2018 May; 94(1111):289-295. PubMed ID: 29374091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normal endothelium.
    Pries AR; Kuebler WM
    Handb Exp Pharmacol; 2006; (176 Pt 1):1-40. PubMed ID: 16999215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The hydrocortisone protection of glycocalyx on the intestinal capillary endothelium during severe acute pancreatitis.
    Gao SL; Zhang Y; Zhang SY; Liang ZY; Yu WQ; Liang TB
    Shock; 2015 May; 43(5):512-7. PubMed ID: 25565639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.